2012
2011
2010
Interferon-λ in HCV Infection and Therapy. Pagliaccetti NE, Robek MD Viruses, 2010 Aug, Volume 2, Issue 8, p.1589-602, (2010)
Inhibition of type III interferon activity by orthopoxvirus immunomodulatory proteins. Bandi P, Pagliaccetti NE, Robek MD Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2010 Mar, Volume 30, Issue 3, p.123-34, (2010)
Bortezomib inhibits hepatitis B virus replication in transgenic mice. Bandi P, Garcia ML, Booth CJ, Chisari FV, Robek MD Antimicrobial agents and chemotherapy, 2010 Feb, Volume 54, Issue 2, p.749-56, (2010)
2013
Protective and pathological properties of IL-22 in liver disease: implications for viral hepatitis. Cobleigh MA, Robek MD The American journal of pathology, 2013 Jan, Volume 182, Issue 1, p.21-8, (2013)
2010
Interferon-lambda in the immune response to hepatitis B virus and hepatitis C virus. Pagliaccetti NE, Robek MD Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2010 Aug, Volume 30, Issue 8, p.585-90, (2010)
2013
2012
2011
2010
Interferon-λ in HCV Infection and Therapy. Pagliaccetti NE, Robek MD Viruses, 2010 Aug, Volume 2, Issue 8, p.1589-602, (2010)
Inhibition of type III interferon activity by orthopoxvirus immunomodulatory proteins. Bandi P, Pagliaccetti NE, Robek MD Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2010 Mar, Volume 30, Issue 3, p.123-34, (2010)
Bortezomib inhibits hepatitis B virus replication in transgenic mice. Bandi P, Garcia ML, Booth CJ, Chisari FV, Robek MD Antimicrobial agents and chemotherapy, 2010 Feb, Volume 54, Issue 2, p.749-56, (2010)
2013